Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,149-20,160 of 23,847
Drug study icon
CompletedNCT00151957

Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

Location not clearly listed
ADHDDrugA study involving a medication or substance.From 6 Years to 12 Years
Countries
Sponsor
Noven Therapeutics
Condition
ADHD
Drug study icon
CompletedNCT00151996

Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

Location not clearly listed
ADHDDrugFrom 6 Years to 17 Years
Countries
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT04981561

Safety and Tolerability of Zelquistinel in Normal Human Volunteers

This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.

Location not clearly listed
DepressionDrugFrom 18 Years to 45 Years
Countries
Sponsor
Syndeio Biosciences, Inc
Condition
Depression
Drug study icon
TerminatedNCT00265382

Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, Colombia, Costa Rica, ...
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00265330

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolarity type I (Manic or Mixed)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

Multiple locations, including Scottsdale
BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT00044005

Safety and Tolerability Study of Drug to Treat Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01922258

Flexible Dosing of Brexpiprazole for Mental health

This study is completed in the United States, in France, in Canada, .... It is testing flexible Dosing of Brexpiprazole for Mental health.

Multiple locations, including Imperial
Mental healthDrugFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Mental health
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.